Experimental Drug Prevents Doxorubicin Heart Damage - Cancer Currents Blog National Cancer Institute sent this bulletin at 04/07/2020 10:32 AM EDT Having trouble viewing this email? View it as a Web page. You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below. Experimental Drug Prevents Doxorubicin from Harming the Heart 04/06/2020 An experimental drug may help prevent the chemotherapy drug doxorubicin from harming the heart and does so without interfering with doxorubicin’s ability to kill cancer cells, according to a study in mice.
